Presidio Property Trust, Inc. (SQFT) - Q2 2024 10-Q Summary
Business Context and Reporting Period
Presidio Property Trust, Inc. is an internally managed Real Estate Investment Trust (REIT) focused on office, industrial, retail, and triple-net leased model home properties. This report covers the quarterly period ended June 30, 2024. The Company is classified as a non-accelerated filer and a smaller reporting company.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2024 | Six Months Ended June 30, 2024 |
|---|---|---|
| Total Revenue | $4.59 million | $9.38 million |
| Net Loss (GAAP) | $(11.38) million | $(15.12) million |
| Net Loss Attributable to Common Stockholders | $(12.39) million | $(18.16) million |
| Net Loss Per Share (Basic & Diluted) | $(1.00) | $(1.47) |
| Net Operating Income (NOI) | $2.99 million | $6.12 million |
| Cash, Cash Equivalents, and Restricted Cash | $8.53 million (as of June 30, 2024) | |
| Total Mortgage Notes Payable (Principal) | ||
| Total Assets | $150.54 million (as of June 30, 2024) | |
| Total Liabilities |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased to $9.38 million for the six months ended June 30, 2024, compared to $8.67 million in the prior year period, driven by new commercial leases and model home transaction fees.
- Significant Non-Cash Loss: The reported net loss was heavily impacted by a $13.89 million unrealized loss on the Company's investment in Conduit Pharmaceuticals (CDT) marketable securities. This compares to no such loss in the prior year period.
- Real Estate Activity: The Company sold 42 model homes for approximately $20.1 million, recognizing a net gain of $2.8 million. Conversely, it acquired 12 new model homes for $5.7 million.
- Impairment Charges: The Company recognized $0.2 million in non-cash impairment charges related to model homes, attributed to short hold periods and builder product style changes in Texas.
- Operating Expenses: General and Administrative (G&A) expenses increased to $4.29 million (six months 2024) from $3.78 million (six months 2023), primarily due to costs associated with the 2024 annual meeting and a settlement with activist stockholder Zuma Capital Management.
Guidance, Outlook, Risks, and Unusual Items
- Debt Maturities: Approximately $25.8 million in commercial property loans mature within the next 12 months. The loan for the Dakota Center property matured on July 6, 2024; negotiations for modification, extension, or sale are ongoing with no final agreement as of August 12, 2024.
- Dividends: The Company paid monthly dividends on Series D Preferred Stock ($0.19531 per share) but declared no cash dividends on Series A Common Stock for the first two quarters of 2024.
- Strategic Alternatives: A Special Committee of the Board is exploring strategic alternatives, including potential business combinations, asset sales, or restructurings, to maximize stockholder value.
- Internal Control Weakness: The Company identified a material weakness in internal controls over financial reporting related to the income tax provision process, specifically concerning REIT/non-REIT subsidiaries and the Conduit de-SPAC transaction. Remediation is in progress.
- Conduit Investment: The Company holds approximately 6.3% of Conduit Pharmaceuticals. The investment value dropped from $18.3 million (Dec 31, 2023) to $4.4 million (June 30, 2024), driving the majority of the GAAP net loss.
Investor Verification Checklist
- Debt Refinancing Status: Verify the outcome of negotiations for the Dakota Center loan and other commercial loans maturing in 2024/2025.
- Conduit Pharmaceuticals Valuation: Monitor the fair value of the Conduit investment and the impact of the Private CDT Warrants on future earnings volatility.
- Common Dividend Policy: Confirm if the Board intends to resume common stock dividends given the suspension in Q1 and Q2 2024.
- Internal Control Remediation: Review progress on fixing the material weakness regarding income tax provisions to ensure future reporting reliability.
- Model Home Portfolio Turnover: Assess the sustainability of the model home acquisition and disposition strategy, particularly regarding impairment risks on short-hold properties.